Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bain

Showing results (291-300 of 303) with videos related to

Pageof 31
Sort By:
Frontiers in Cellular and Infection Microbiology|April 14, 2023
Phagocytosis is a primary determinant of pulmonary clearance of clinical <i>Klebsiella pneumoniae</i> isolatesRick van der Geest, Hongye Fan, Hernán F Peñaloza, et al.
Gastroenterology|July 6, 2010
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3David R Nelson, Yves Benhamou, Wan-Long Chuang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 9, 2016
Transducer-based evaluation of tremorDietrich Haubenberger, Giovanni Abbruzzese, Peter G Bain, et al.
Chest|November 20, 2020
Lower Respiratory Tract Myeloid Cells Harbor SARS-Cov-2 and Display an Inflammatory PhenotypeWilliam G Bain, Hernán F Peñaloza, Mark S Ladinsky, et al.
Clinical Pharmacology and Therapeutics|February 26, 2010
Pharmacodynamics and pharmacokinetics of AM103, a novel inhibitor of 5-lipoxygenase-activating protein (FLAP)G Bain, C D King, M Rewolinski, et al.
Immunohorizons|January 30, 2024
STAT1 Employs Myeloid Cell-Extrinsic Mechanisms to Regulate the Neutrophil Response and Provide Protection against Invasive Klebsiella pneumoniae Lung InfectionShekina Gonzalez-Ferrer, Hernán F Peñaloza, Rick van der Geest, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 17, 2010
Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonistJ S Swaney, C Chapman, L D Correa, et al.
Critical Care Explorations|March 24, 2025
Glucagon-Like Peptide-1 Is Prognostic of Mortality in Acute Respiratory FailureCole E Hansell, Hamam A Aneis, Georgios D Kitsios, et al.
Journal of the American Heart Association|May 6, 2026
Soluble Thrombomodulin Links Viremia and Mortality During COVID-19: Results From the ACTIV-4a TrialBenjamin E Zuchelkowski, Kyle W Inman, S Mehdi Nouraie, et al.
American Journal of Respiratory Cell and Molecular Biology|February 1, 2024
Lung Epithelium Releases Growth Differentiation Factor 15 in Response to Pathogen-mediated InjuryFaraaz A Shah, Harinath Bahudhanapati, Mao Jiang, et al.
Pageof 31

Showing results (291-300 of 303) with videos related to

Sort By:
Pageof 31
Frontiers in Cellular and Infection Microbiology|April 14, 2023
Phagocytosis is a primary determinant of pulmonary clearance of clinical <i>Klebsiella pneumoniae</i> isolatesRick van der Geest, Hongye Fan, Hernán F Peñaloza, et al.
Gastroenterology|July 6, 2010
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3David R Nelson, Yves Benhamou, Wan-Long Chuang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 9, 2016
Transducer-based evaluation of tremorDietrich Haubenberger, Giovanni Abbruzzese, Peter G Bain, et al.
Chest|November 20, 2020
Lower Respiratory Tract Myeloid Cells Harbor SARS-Cov-2 and Display an Inflammatory PhenotypeWilliam G Bain, Hernán F Peñaloza, Mark S Ladinsky, et al.
Clinical Pharmacology and Therapeutics|February 26, 2010
Pharmacodynamics and pharmacokinetics of AM103, a novel inhibitor of 5-lipoxygenase-activating protein (FLAP)G Bain, C D King, M Rewolinski, et al.
Immunohorizons|January 30, 2024
STAT1 Employs Myeloid Cell-Extrinsic Mechanisms to Regulate the Neutrophil Response and Provide Protection against Invasive Klebsiella pneumoniae Lung InfectionShekina Gonzalez-Ferrer, Hernán F Peñaloza, Rick van der Geest, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 17, 2010
Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonistJ S Swaney, C Chapman, L D Correa, et al.
Critical Care Explorations|March 24, 2025
Glucagon-Like Peptide-1 Is Prognostic of Mortality in Acute Respiratory FailureCole E Hansell, Hamam A Aneis, Georgios D Kitsios, et al.
Journal of the American Heart Association|May 6, 2026
Soluble Thrombomodulin Links Viremia and Mortality During COVID-19: Results From the ACTIV-4a TrialBenjamin E Zuchelkowski, Kyle W Inman, S Mehdi Nouraie, et al.
American Journal of Respiratory Cell and Molecular Biology|February 1, 2024
Lung Epithelium Releases Growth Differentiation Factor 15 in Response to Pathogen-mediated InjuryFaraaz A Shah, Harinath Bahudhanapati, Mao Jiang, et al.
Pageof 31